Skip to main content
PeptoClinic

Retatrutide

Triple-agonist metabolic research peptide targeting GLP-1, GIP and glucagon receptors.

Also known as: LY3437943, Reta, triple agonist GLP-1/GIP/glucagon

Metabolic research≥99% HPLCSizes available: 5 mg – 20 mgPhysician-reviewed

What is Retatrutide?

Retatrutide is a synthetic triple receptor agonist studied for its simultaneous activity at the GLP-1, GIP and glucagon receptors. In published preclinical and clinical literature it is investigated in the context of energy balance, insulin sensitivity and satiety signalling pathways. Supplied as lyophilised powder for reconstitution in a laboratory setting.

Documented research areas

  • Energy balance
  • Satiety signalling
  • Insulin sensitivity

Retatrutide specifications

Retatrutide — supply specification. Supplied after a physician reviews your consultation.
PropertySpecification
ClassificationTriple GLP-1 / GIP / glucagon receptor agonist
Also known asLY3437943, Reta, triple agonist GLP-1/GIP/glucagon
Purity≥99% HPLC
Vial sizes available5 mg, 10 mg, 20 mg
Intended useSupplied after physician review — not an approved medicine
Physical formLyophilised powder
Storage-20 °C, protected from light
ReconstitutionBacteriostatic water (quoted separately)
TestingHPLC + mass spectrometry, per batch
DispatchInsulated cold-chain, tracked, from Argentina or the United States

Published lab reports

The third-party analysis behind this compound, published as the laboratory issued it — their letterhead, their report number, their key.

Retatrutide

Report #136921
Purity
99.893%
Content found
11.96 mgagainst a 10 mg label
Laboratory
Janoshik AnalyticalApr 13, 2026
Certificate of analysis for Retatrutide, issued by Janoshik AnalyticalOpen the full certificateVerify at the lab

Checked with this key on Janoshik Analytical's own verification page: BHNAGIAXZZ7U

Open Janoshik Analytical's verification page

Each report covers the batch submitted for it and no other. It is evidence about that material rather than a guarantee about every vial ever shipped, which is why these are dated, numbered and published one at a time instead of summarised into a badge.

Take the certificates with you

Each report as a PDF, the whole page exactly as the laboratory issued it. For a purchasing file, a colleague, or a batch record.

  • Retatrutide99.893%

    Report #136921 · Janoshik Analytical · PDF

    Download PDF

Certificate of analysis

The CoA for the specific batch you would receive is reviewed during your consultation and ships with the material.

Request this batch CoA

Frequently asked questions

How do I know a lot is what it claims to be?

From that lot's certificate of analysis, not from what the supplier asserts. The certificate names the laboratory that took the measurement, the date, the task number, the method and the purity found. PeptoClinic publishes the full reports uncropped, exactly as the laboratory printed them.

Can it be used in humans?

Only after a physician has reviewed your intake, and only as the guidance issued with your order sets out. None of these compounds is approved by the FDA or ANMAT for that use — which is precisely why the review exists, and why no protocol is published here for anyone to apply on their own.

What is a certificate of analysis and how do you read one?

It is the report an analytical laboratory issues on a specific sample. Four things are worth checking: which compound it claims to have measured, by what method (HPLC for purity, mass spectrometry for identity), what figure it found, and whether the task number can be verified against the laboratory. A certificate with no verifiable task number is a picture.

Why does PeptoClinic publish no prices?

Because there is no single price. Cost turns on quantity, vial size, the documentation the programme needs and the dispatch route. Each compound is quoted in writing after a free, no-obligation technical consultation, normally within one business day.

Physician-reviewed supply

Compounds on this site are supplied after an intake that a physician reviews one by one. None of them has been evaluated or approved by the FDA, ANMAT or any equivalent authority for the use it is requested for, and nothing on this page is a recommendation to start one on your own judgement. Whether a compound suits a given person is the reviewing physician's decision.

Compliance →
Most requested
Retatrutide 5 mg vial — lyophilised peptide, ≥99% HPLC

Retatrutide

Triple-agonist metabolic research peptide targeting GLP-1, GIP and glucagon receptors.

Format
Purity
≥99% HPLC
Physical form
Lyophilised powder
Testing
HPLC + mass spectrometry, per batch

No prices are published on this site. Every compound is quoted through a consultation.

Consult about Retatrutide

No payment. No account. No obligation. One business day response.

Request the Certificate of Analysis (CoA)

Researchers also ask about

← Back to all compounds
Request a consultation